MannKind

+$0.16 (+4.26%) Today
-$0.02 (-0.51%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.

About MNKD

MannKind Corp. operates as a biopharmaceutical company. It focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

CEO
Michael E. Castagna
Employees
241
Headquarters
Danbury, Connecticut
Founded
1991

MNKD Key Statistics

Market cap
984.92M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.43M
High today
$3.95
Low today
$3.68
Open price
$3.72
Volume
2.91M
52 Week high
$6.25
52 Week low
$3.12

MNKD News

ReutersJan 14

MNKD.OQ - MannKind Corporation Profile

About MannKind Corporation MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled ther
Simply Wall StJan 11

How Much Of MannKind Corporation Do Institutions Own?

The big shareholder groups in MannKind Corporation (NASDAQ:MNKD) have power over the company. Insiders often own a large chunk of younger, smaller, companies wh

MNKD Earnings

-$0.07
-$0.05
-$0.02
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure